tiprankstipranks
Trending News
More News >
Clinuvel Pharmaceuticals Limited (AU:CUV)
ASX:CUV
Australian Market

Clinuvel Pharmaceuticals (CUV) Income Statement

Compare
70 Followers

Clinuvel Pharmaceuticals Income Statement

Last quarter (Q2 2025), Clinuvel Pharmaceuticals 's total revenue was AU$35.65M, an increase of 21.44% from the same quarter last year. In Q2, Clinuvel Pharmaceuticals 's net income was AU$14.08M. See Clinuvel Pharmaceuticals ’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 88.18MAU$ 78.32MAU$ 65.72MAU$ 47.98MAU$ 32.57M
Gross Profit
AU$ 80.45MAU$ 50.59MAU$ 46.62MAU$ 35.20MAU$ 18.43M
Operating Expenses
AU$ 31.30MAU$ 9.68MAU$ 13.53MAU$ 8.51MAU$ 8.23M
Depreciation and Amortization
AU$ 1.14MAU$ 789.41KAU$ 757.83KAU$ 861.43KAU$ 446.13K
EBITDA
AU$ 51.86MAU$ 46.37MAU$ 35.08MAU$ 26.57MAU$ 11.99M
Operating Income
AU$ 48.01MAU$ 40.91MAU$ 33.08MAU$ 26.70MAU$ 10.20M
Other Income/Expenses
AU$ 2.67MAU$ 1.48MAU$ -1.77MAU$ -983.49KAU$ -1.16M
Pretax Income
AU$ 50.68MAU$ 45.58MAU$ 34.32MAU$ 25.71MAU$ 11.54M
Net Income
AU$ 35.64MAU$ 30.60MAU$ 20.88MAU$ 24.73MAU$ 16.65M
Per Share Metrics
Basic EPS
AU$ 0.72AU$ 0.62AU$ 0.42AU$ 0.50AU$ 0.31
Diluted EPS
AU$ 0.70AU$ 0.59AU$ 0.40AU$ 0.48AU$ 0.30
Weighted Average Shares Outstanding
51.05M 49.41M 49.41M 49.41M 49.26M
Weighted Average Shares Outstanding (Diluted)
51.03M 51.82M 51.78M 51.13M 50.46M
Currency in AUD

Clinuvel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis